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NagZ is a glycoside hydrolase that participates in
peptidoglycan (PG) recycling by removing b-N-ace-
tylglucosamine from PG fragments that are excised
from the bacterial cell wall during growth. Notably,
the products formed by NagZ, 1,6-anhydroMurNAc-
peptides, activate b-lactam resistance in many
Gram-negative bacteria, making this enzyme of
interest as a potential therapeutic target. Crystal
structure determinations of NagZ from Salmonella
typhimurium and Bacillus subtilis in complex with
natural substrate, trapped as a glycosyl-enzyme
intermediate, and bound to product, define the reac-
tion coordinate of the NagZ family of enzymes. The
structures, combined with kinetic studies, reveal an
uncommon degree of structural plasticity within the
active site of a glycoside hydrolase, and unveil how
NagZ drives substrate distortion using a highly
mobile loop that contains a conserved histidine that
has been proposed as the general acid/base.
INTRODUCTION
The cell wall of bacteria is strengthened by a layer of peptido-
glycan (PG) to withstand intracellular turgor pressure and main-
tain cellular shape. PG is a mesh-like heteropolymer of glycan
strands, composed of alternating b-1,4-linked N-acetylglucos-
amine (GlcNAc) and N-acetylmuramic acid (MurNAc) sugars
that are crosslinked by short peptides (Vollmer et al., 2008).
Despite its structural role, PG is a remarkably dynamic macro-
molecule that is continuously reconstructed as bacteria grow
and divide (Typas et al., 2012). In the model Gram-negative
bacterium Escherichia coli, lytic transglycosylases and endo-
peptidases turn over about 50% of the PG layer per genera-
tion by releasing GlcNAc-b(1/4)-1,6-anhydroMurNAc-peptide
(GlcNAc-anhMurNAc-peptide) fragments into the periplasmic
space (Goodell, 1985; Park and Uehara, 2008). The fragments
are transported into the cytosol, where a series of enzymes
recycles these materials (Ho¨ltje, 1998) into UDP-MurNAc-penta-
peptide, the building block used to synthesize PG (for a review,
see Park and Uehara, 2008).Chemistry & Biology 19, 1471–148An early step in PG recycling is the removal of the terminal
GlcNAc sugar from internalized PG fragments by the exo-acting
b-N-acetylglucosaminidase NagZ (Cheng et al., 2000; Vo¨tsch
and Templin, 2000). The enzyme yields free GlcNAc and a pool
of cytosolic anhMurNAc and anhMurNAc-peptides, with the
anhMurNAc-peptide species serving as signaling molecules
that induce high-level chromosomal AmpC b-lactamase
(AmpC) expression in various Gram-negative bacteria (Dietz
et al., 1997; Jacobs et al., 1997). AmpC is of considerable
medical importance, because it confers broad-spectrum resis-
tance to b-lactam antibiotics in the opportunistic human path-
ogen Pseudomonas aeruginosa and other nonfermenting
Gram-negative bacilli, as well as many Enterobacteriaceae (Liv-
ermore, 1995). Because disruption of NagZ activity impedes
formation of anhMurNAc and anhMurNAc-peptides, which limits
AmpC production and reverses resistance to b-lactams in Gram-
negative bacteria, the enzyme has attracted attention as a poten-
tial therapeutic target (Asgarali et al., 2009; Balcewich et al.,
2009; Huang et al., 2012; Stubbs et al., 2007; Yamaguchi
et al., 2012; Zamorano et al., 2010).
Orthologs of NagZ have also been found to participate in the
PG recycling pathway of Gram-positive bacteria (Reith and
Mayer, 2011). In these microbes, the enzyme removes GlcNAc
from GlcNAc-MurNAc-peptides (Litzinger et al., 2010a) that are
generated by muramidases as opposed to lytic transglycosy-
lases (van Heijenoort, 2011). NagZ of both Gram-negative
and -positive bacteria belong to glycoside hydrolase family 3
(GH3) (Cantarel et al., 2009), a large group of sequence-related
yet functionally diverse enzymes that includes b-N-acetylgluco-
saminidases, b-glucosidases, and b-xylosidases, among others.
GH3 enzymes remove terminal sugars from substrates using a
two-step, double-displacement mechanism involving the forma-
tion and breakdown of a covalent glycosyl-enzyme intermediate
via oxocarbenium ion-like transition states (Figure 1) (Vocadlo
et al., 2000; Vocadlo and Withers, 2005). In the first step, an
enzymic nucleophile attacks the anomeric carbon (C1) of the
nonreducing sugar while the leaving group departs, with the
net result being the formation of a covalent glycosyl-enzyme
intermediate. A second catalytic residue assists with cleavage
of the glycosidic bond by acting as a general acid to deliver
a proton to the leaving group. In the second step, this same
residue now acts as a general base to enhance the nucleophi-
licity of an incoming water molecule, facilitating its attack at
the anomeric carbon of the covalent intermediate. The attack2, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1471
Figure 1. Catalytic Mechanism of NagZ Enzymes
The enzymes use a two-step, double-displacement mechanism involving the formation and breakdown of a covalent glycosyl-enzyme intermediate via
oxocarbenium ion-like transition states (Vocadlo et al., 2000; Vocadlo and Withers, 2005). A histidine is proposed to act as the general acid/base (Litzinger et al.,
2010b).
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Snapshots along the Reaction Coordinate of NagZbywater displaces the enzymic nucleophile and releases a hemi-
acetal sugar product with an anomeric configuration matching
that of the substrate. This general retaining mechanism, in-
volving two active site carboxyl residues, is used by the majority
of configuration-retaining b-glycosidases (Vocadlo and Davies,
2008).
The catalytic nucleophile within family GH3 has been identified
as a conserved aspartate residue (Chir et al., 2002; Dan et al.,
2000; Hrmova et al., 2001; Vocadlo et al., 2000). The general
acid/base residue, however, is poorly conserved among GH3
enzymes. The two-domain GH3 b-glucanase from the barley
Hordeum vulgare (HvExoI) (Varghese et al., 1999) has an
N-terminal domain that adopts a characteristic (b/a)8 barrel
fold (TIM-barrel) with an active site located at the C terminus of
the b barrel. Interestingly, whereas the aspartate nucleophile is
found within the active site, the general acid/base catalytic
residue is a glutamate residue that projects into the active site
from the C-terminal domain. Studies of additional multidomain
GH3 b-glucosidases have since shown that this unusual bido-
main active site architecture is a common feature of multidomain
GH3 b-glucanases (Nakatani et al., 2012; Pozzo et al., 2010;
Yoshida et al., 2010). Moreover, structural studies of HvExoI
b-glucanase bound to substrate (Hrmova et al., 2001) and
modeling studies of additional multidomain GH3 b-glucosidases
(Nakatani et al., 2012; Yoshida et al., 2010) have found no
evidence that GH3 enzymes distort the substrate as part of their
catalytic mechanism, unlike several other families of configura-
tion-retaining GH enzymes (Davies et al., 2012).
In contrast, the majority of GH3 NagZ enzymes from Gram-
negative bacteria are single-domain enzymes. Crystal structures
of NagZ from Vibrio cholerae (VcNagZ) (Protein Data Bank [PDB]1472 Chemistry & Biology 19, 1471–1482, November 21, 2012 ª2012ID code 1TR9) (Stubbs et al., 2007) and the extremophile Deino-
coccus radiodurans (DrNagZ) (PDB ID code 3TEV) reveal that
these enzymes adopt a TIM-barrel fold similar to the N-terminal
domain of the multidomain GH3 b-glucosidases. Whereas the
conserved aspartate nucleophile is present in the active site,
a residue able to function as the catalytic acid/base is conspic-
uously absent. A recent crystal structure of NagZ from the
Gram-positive microbe Bacillus subtilis (BsNagZ), determined
in complex with the potent b-N-acetylglucosaminidase inhibitor
PUGNAc (Beer et al., 1990), has provided some insight into the
identity of the catalytic acid/base (Litzinger et al., 2010b).
Although BsNagZ is a two-domain GH3 enzyme, only the
N-terminal TIM-barrel domain was found to participate in catal-
ysis: a histidine, located on a flexible loop that is conserved
within the TIM-barrel domain of GH3 NagZ enzymes, was found
positioned within the active site so that the imidazole ring inter-
acted with the inhibitor in a manner consistent with it functioning
as the general acid/base catalyst (Litzinger et al., 2010b).
The proposal that a histidine residue acts as a general acid
is surprising, because the general acid/base residue is nearly
universally a carboxyl residue within all families of glycoside
hydrolases (Vocadlo and Davies, 2008). Intriguingly, the loop
containing this histidine is flipped outward toward the solvent
or disordered in crystal structures of the single-domain NagZ
enzymes from V. cholerae and D. radiodurans, leaving un-
certainty as to how these enzymes coordinate catalysis
because retaining b-glycosidases typically have rigid active
site architectures.
Through X-ray structural studies of two NagZ enzymes
in complex with their natural substrates, a trapped glycosyl-
enzyme intermediate, and product complex, we find that theElsevier Ltd All rights reserved
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Snapshots along the Reaction Coordinate of NagZloop containing the proposed catalytic histidine undergoes
significant structural changes during catalysis, which to our
knowledge is unprecedented within the active site of a glycoside
hydrolase. The changes in loop orientation alter binding of the
substrate and drive catalysis along a 1S34
4H34
4C1 conforma-
tional itinerary. The studies reported here provide support for the
proposal of a noncanonical histidine acting as the general cata-
lytic acid/base residue within NagZ and its orthologs. The struc-
tures also provide blueprints of these enzymes in their open and
closed conformations in complex with their natural substrates,
which should facilitate the design of potent inhibitors of these
medically relevant enzymes.
RESULTS AND DISCUSSION
Family GH3 NagZ enzymes can be identified by the unique
consensus motif [KH(F/I)PG(H/L)GXXXXD(S/T)H] (Vocadlo
et al., 2000), which comprises part of the 1 subsite of the
active site and loop motif that contains a histidine proposed
to act as the general acid/base residue (in bold) (Litzinger
et al., 2010b) (for subsite nomenclature, see Davies et al.,
1997). We were intrigued by the suggestion that a histidine
might be acting as the general acid/base residue given the
preponderance of data revealing carboxyl groups as fulfilling
this role in glycoside hydrolases (Vocadlo and Davies, 2008).
This proposal was advanced on the basis of structural studies
using an enzyme-inhibitor complex, which may not have reca-
pitulated the same binding interactions as would be seen with
a natural disaccharide substrate. Furthermore, we noted that
the loop containing the catalytic histidine (hereafter named the
‘‘catalytic loop’’) is highly mobile in NagZ enzymes in both
Gram-negative (Stubbs et al., 2007) and Gram-positive bacteria
(PDB ID codes 3LK6 and 3TEV). To clarify the identity of the
general acid/base, evaluate the functional significance of the
mobility of the catalytic loop, elucidate the conformational itin-
erary of the substrate during catalysis, and gain insight that
might aid the design of more effective inhibitors of NagZ
enzymes, we set out to obtain structures of stable species
along the reaction coordinate of NagZ from Gram-negative
species that are involved in AmpC-mediated antibiotic
resistance.
Studies using isolated cell-wall fragments showed that E. coli
NagZ removes GlcNAc from both GlcNAc-anhMurNAc and
GlcNAc-anhMurNAc-peptide with similar efficiencies (Cheng
et al., 2000; Vo¨tsch and Templin, 2000). Given these observa-
tions and the knowledge that GlcNAc-anhMurNAc disaccharide
itself is likely formed within E. coli (Jacobs et al., 1995; Lee
et al., 2009), we chemically synthesized GlcNAc-anhMurNAc
(1) according to Paulsen (Paulsen et al., 1986) (Figure S1 avail-
able online) and tested it as a substrate for Salmonella typhimu-
rium NagZ (StNagZ). StNagZ is a homolog of both E. coli NagZ
and V. cholerae NagZ (VcNagZ), the latter of which we have
examined structurally (Balcewich et al., 2009; Stubbs et al.,
2007). We found GlcNAc-anhMurNAc (Figure S2) was efficiently
processed by the enzyme (kcat = 1.7 ± 0.05 s
1, Km = 59 ±
6 mM, kcat/Km = 2.2 ± 0.2 mM min
1 mg1), and structural
analogs in which the carboxylate of the lactyl group were
replaced with a methyl ester (2) or amide (3) (Figures S2 and
S3) were also found to be equally good substrates of StNagZChemistry & Biology 19, 1471–148when assayed qualitatively (Figures S2 and S3). The substrate
analogs were used to evaluate the possibility of substrate-
assisted catalysis, wherein the carboxyl group of the lactyl
substituent could serve as the general acid/base during catal-
ysis. Because StNagZ was similarly active against all three
substrate analogs, we concluded that the lactyl carboxyl group
does not participate in catalysis.
Crystal Structure Determinations of StNagZ Bound
to a Disaccharide Substrate
The crystal structure of unliganded StNagZ was determined by
molecular replacement (MR) using the VcNagZ structure (PDB
ID code 2OXN) as a search model and refined to 1.7 A˚ resolution
(Table S1). We focused on StNagZ rather than VcNagZ because,
unlike the latter enzyme (Balcewich et al., 2009; Stubbs et al.,
2007), StNagZ could be readily bound to ligands by soaking
them directly into crystals of the enzyme (Table S2). The unli-
ganded structure of StNagZ served as the starting model for
MR structures of ligand-bound forms of the enzyme.
Structural determinations of wild-type StNagZ using crystals
that had been soaked with GlcNAc-anhMurNAc revealed
electron density for only the GlcNAc product in the active site,
suggesting that StNagZ turned over the disaccharide in the
crystalline state (data not shown). To obtain intact GlcNAc-
anhMurNAc bound in the active site, the conserved catalytic
nucleophile was mutated to asparagine (Asp248Asn) to gen-
erate an enzyme with no discernible activity. Crystals of this
variant were soaked with the disaccharide substrate, and
a structure of the complex was determined to 1.55 A˚ resolution
(Table S1). Whereas this yielded well-defined electron density
for GlcNAc-anhMurNAc within the active site, the catalytic
loop of the enzyme was pointed outward toward the solvent
(Figure 2A). As a consequence, the histidine residue proposed
in NagZ enzymes to act as the general acid/base (for StNagZ,
His176) was located over 15 A˚ away from the glycosidic oxygen
of the bound substrate (Figures 2 and 3A). Moreover, the disac-
charide was bound in an energetically relaxed conformation in
which the pyranose of the GlcNAc residue adopted a 4C1 chair
conformation in the 1 subsite, and the Asp248Asn side chain
was oriented in a manner inconsistent with it serving as a cata-
lytic nucleophile (Figure 3B). The absence of substrate distortion
was consistent with structures of a thioglycoside substrate
analog bound to HvExoI (Hrmova et al., 2001); however, it
was a surprising observation, because the pyranose ring of
substrates bound to the 1 subsite of retaining glycoside
hydrolases is typically distorted toward a 1S3 conformation to
allow the leaving group to adopt a pseudoaxial orientation
within the active site. This distortion allows the catalytic nucle-
ophile to attack the anomeric center in line with the leaving
group (Davies et al., 2012).
On the basis of these observations, we speculated that the
complex may reflect a ‘‘pre-Michaelis’’ conformation of the
bound substrate and that a subsequent distorted substrate
conformation might occur that would accommodate reposition-
ing of the catalytic loop into the active site. Despite numerous
crystallization trials, we were unable to trap the substrate bound
to StNagZ as a Michaelis complex with the catalytic loop posi-
tioned within the active site. We therefore turned to molecular
modeling of StNagZ to gain insight into this question.2, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1473
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Figure 2. Crystal Structures of StNagZ and
BsNagZ Bound to Disaccharide Substrate
(A) StNagZ bound to GlcNAc-anhMurNAc (see
Figure S1 for synthesis).
(B)BsNagZ bound toGlcNAc-MurNAc (monoclinic
form).
(C) BsNagZ bound to distorted GlcNAc-MurNAc
(triclinic form).
(D) Superposition of the catalytic domains of
BsNagZ and StNagZ.
Crystal structures are shown as cartoon repre-
sentations with ligands shown as spheres. The
conserved NagZ consensus motif [KH(F/I)PG(H/L)
GXXXXD(S/T)H] containing the mobile catalytic
loop is shown in cyan for StNagZ, green for
BsNagZ (monoclinic form), and blue for BsNagZ
(triclinic form). Loop thickness is correlated to
thermal B factors (thicker loops have higher
mobility). The proposed general acid/base histi-
dine is shown in stick format. For BsNagZ, the
N-terminal domain is shown in salmonwhereas the
C-terminal domain is shown in dark salmon.
StNagZ and the N-terminal domain of BsNagZ
(residues 25–420) adopt a TIM-barrel fold con-
taining the enzyme active site. The C-terminal
domain of BsNagZ (residues 421–642) adopts
a noncatalytic aba sandwich fold that does not
come into close contact with the enzyme active
site. All structural figures were made using PyMOL
(DeLano, 2002).
See also Figures S1–S3 and Tables S1 and S2.
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Snapshots along the Reaction Coordinate of NagZMolecular Modeling and Functional Analysis Suggest
Substrate Distortion Occurs in StNagZ
The glycosidic bond of the disaccharide in the StNagZ-GlcNAc-
anhMurNAc complex (Figure 3C) was modeled in a pseudoaxial
orientation as observed for other configuration-retaining
b-glycosidases (Davies et al., 1998, 2012; He et al., 2010; Papa-
nikolau et al., 2001; Sulzenbacher et al., 1996; Tews et al., 1997),
which placed the anhMurNAc leaving group into a pocket that
we speculated to be the +1 subsite (Figure 3C). The distortion
was readily accommodated, and we observed that Arg70 within
the putative +1 subsite was well positioned to interact with the
lactyl group of the anhMurNAc residue through hydrogen
bonding (Figure 3C), supporting the model as a viable species.
The distorted conformation created space in the active site
that enabled repositioning of the catalytic loop such that the
proposed general acid/base residue, His176, could interact
directly with the glycosidic oxygen, as based on the loop con-
formation and interaction observed between His234 of BsNagZ
and the oxime nitrogen of PUGNAc (Litzinger et al., 2010b).
The catalytic nucleophile (Asp248) could also now be positioned
in line with the glycosidic bond, consistent with this being
a general requirement for glycoside hydrolases (Davies et al.,
2012). We found the His176Gly variant to have significantly
impaired activity (kcat = 2.7 3 10
4 ± 0.1 3 104 s1, Km =
27 ± 3 mM, kcat/Km = 0.076 ± 0.01 mM min
1 mg1) relative to
the wild-type enzyme (kcat = 5.7 3 10
3 ± 0.1 3 103 s1,
Km = 120 ± 14 mM, kcat/Km = 0.37 ± 0.04 mM min
1 mg1)
when using 4-Mu b-GlcNAc as a substrate, a trend in keeping
with the change in activity observed when the analogous
residue, His234, was swapped for glycine in BsNagZ (Litzinger
et al., 2010b). Encouraged by these results, which supported1474 Chemistry & Biology 19, 1471–1482, November 21, 2012 ª2012the feasibility of substrate distortion being coupled to reorgani-
zation of the catalytic loop, we set out to evaluate this possibility
in homologous NagZ enzymes.
BsNagZ Binds Disaccharide Substrate in Both a Relaxed
and Distorted Conformation
Given that the catalytic loop of BsNagZ has been observed in
a conformation that allowed the imidazole group of His234
to interact directly with a bound molecule of PUGNAc, we antic-
ipated that further study of this enzyme could validate
our hypothesis that substrate distortion occurs within NagZ
enzymes. Consequently, a variant of BsNagZ in which the cata-
lytic nucleophile had been mutated to asparagine (Asp318Asn)
was crystallized in complex with the substrate GlcNAc-MurNAc
(as for StNagZ, BsNagZ activity does not depend on the pres-
ence of the stem peptide; Litzinger et al., 2010a). The enzyme
was grown in both triclinic and monoclinic crystal forms, and
each retained excellent diffraction quality after soaking with the
disaccharide (Tables S1 and S2). Structures of the triclinic and
monoclinic forms of the enzyme bound to disaccharide were
determined by MR and refined to 1.65 and 1.8 A˚ resolution,
respectively (Figures 2B and 2C). Although the catalytic domain
of StNagZ bears only 28% similarity to the N-terminal catalytic
TIM-barrel domain of BsNagZ (residues 25–420), the domains
superimposed very closely (root-mean-square deviation, 2.1 A˚,
a residues 1–308) (Figure 2D).
A superposition of the two substrate-bound structures
of BsNagZ with the structure of StNagZ bound to GlcNAc-
anhMurNAc revealed that the active site residues that bind the
terminal GlcNAc sugar within the 1 subsite of each enzyme
were completely conserved and exhibited little flexibility in theElsevier Ltd All rights reserved
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Snapshots along the Reaction Coordinate of NagZpresence or absence of substrate (Figures 3 and 4). Conversely,
the conformation of the catalytic loop varied greatly between
these structures (Figures 2 and 3A). For the triclinic crystal
form of BsNagZ, the catalytic loop was positioned within the
active site such that imidazole ring nitrogen Nε2 of His234 was
within 2.8 A˚ of the glycosidic oxygen of the GlcNAc-MurNAc
substrate. This is an ideal distance to deliver a proton to the de-
parting glycosidic oxygen (Figures 3A and 3D), and provides
further support for the assignment of this conserved residue as
the general catalytic acid/base in GH3 NagZ enzymes. In
contrast, the catalytic loop in the monoclinic BsNagZ substrate
complex was flipped outward from the active site toward solvent
similar to the StNagZ substrate complex described above,
placing their respective catalytic general acid/base residues,
His234 and His176, as much as 23.8 A˚ away from the position
of the substrate glycosidic oxygen (Figures 3A and 3E).
A remarkable feature of these crystal structures was the corre-
lation between the position of the catalytic loop and the confor-
mation of the disaccharide substrate within the active site of
each enzyme. When the catalytic loop was flipped outward
toward the solvent, as in the StNagZ-GlcNAc-anhMurNAc and
monoclinic BsNagZ-GlcNAc-MurNAc crystal structures, the
disaccharide substrate bound the enzyme in a relaxed confor-
mation, with the GlcNAc sugar adopting a 4C1 chair conforma-
tion in the 1 subsite (Figures 3B and 3E). However, in the
triclinic BsNagZ-GlcNAc-MurNAc crystal structure, where the
catalytic loop was folded in toward the active site, the scissile
bond (C1-OR) of the disaccharide was found in a pseudoaxial
orientation, which was facilitated by distortion of the GlcNAc
sugar within the 1 subsite toward a 1S3 skew-boat conforma-
tion (Figure 3D). The distortion placed the C1-OR bond and
leaving group in line with the mutated enzymic nucleophile (As-
p318Asn) and provided space for the catalytic loop to enter the
active site and place His234 within hydrogen-bonding distance
of the glycosidic oxygen.
The distortion also placed the MurNAc leaving group into a +1
subsite that was consistent with ourmodeling studies ofStNagZ.
Although structural differences exist between StNagZ and
BsNagZ +1 binding sites (likely due to differences in the
substrates these enzymes catabolize in vivo), it is notable that
a conserved arginine residue in BsNagZ (Arg131) appeared to
assist substrate distortion by binding the MurNAc sugar within
the +1 subsite via interactions with the lactyl group (Figure 3D).
Similarly, we predicted that Arg70 of StNagZ would bind the lac-
tyl moiety of anhMurNAc in the +1 subsite upon rearrangement
of the leaving group into a pseudoaxial orientation (Figure 3C).
Taken together, these observations provide strong support for
our model of substrate distortion in StNagZ and indicate that
catalytic loop mobility and substrate distortion are common
features of NagZ enzymes.
Capturing substrate complexes of StNagZ and BsNagZ with
the catalytic loop flipped outward to the solvent, in conjunction
with our model of StNagZ and crystal structure of BsNagZ where
the catalytic loop engages a distorted form of the substrate
within the active site, supports the idea that NagZ enzymes alter-
nate between these conformations during the catalytic cycle.
Notably, a superposition of the triclinic and monoclinic BsNagZ
substrate complexes clearly reveals that when the catalytic
loop is poised for catalysis, as in the triclinic complex, the cata-Chemistry & Biology 19, 1471–148lytic histidine, His234, would clash with the MurNAc sugar if the
substrate were bound to enzyme in an undistorted conformation
(as observed in the monoclinic crystal of BsNagZ). This observa-
tion suggests that reorientation of the catalytic loop promotes
substrate distortion. A likely scenario is that the catalytic loop
initially juts outward to facilitate the capture of substrates in a
relaxed conformation as a pre-Michaelis complex. After binding,
the substrate likely samples various conformations, including
a 1S3 conformation that has the scissile bond in a pseudoaxial
orientation. In this conformation, the MurNAc sugar is positioned
within the +1 subsite and the catalytic loop enters the active site,
stabilizing the distorted substrate and engaging all of the cata-
lytic machinery. These sequential, or perhaps coordinated,
movements result in a productive Michaelis complex where the
proposed general acid/base histidine engages the glycosidic
oxygen and the catalytic nucleophile is in line with the pseudoax-
ial orientation of the scissile bond and leaving group.
Observation of a Glycosyl-Enzyme Intermediate for
StNagZ
Studies using chemical labeling with 2-acetamido-2-deoxy-5-
fluoro-a-L-idopyranosyl fluoride identified a conserved aspartate
in Vibrio furnisii NagZ (Asp242) as the catalytic nucleophile
(Vocadlo et al., 2000). Mutational analysis of this residue in
BsNagZ (Asp318Asn) and StNagZ (Asp248Asn) reveals these
variants are inactive. These data, in conjunction with the triclinic
structure of BsNagZ showing Asn318 within 3.9 A˚ of the GlcNAc
anomeric center of the MurNAc-GlcNAc substrate, support the
identity of this conserved Asp as the nucleophile (Figure 3D).
Interestingly, structures of StNagZ revealed Asp248 resides on
a flexible loop. Indeed, in the unliganded structure of the enzyme,
the carboxylate of Asp248 was turned away from the1 subsite
(Figure 4A), as was the asparagine side chain in the Asp248Asn
variant of the enzyme when bound to GlcNAc-MurNAc
(Figure 3B).
We aimed to confirm the role of Asp248 in StNagZ and deter-
mine the conformation of the pyranose ring in the covalent
glycosyl-enzyme intermediate by trapping the wild-type enzyme
with 2-acetamido-2-deoxy-5-fluoro-b-D-glucopyranosyl fluoride
(5-F-GlcNAc-F) (Stubbs et al., 2008). Crystals of the enzyme
were soaked with 5-F-GlcNAc-F and the complex was deter-
mined by MR and refined to 1.45 A˚ resolution (Table S1). Inspec-
tion of the electron density revealed that the carboxylate of
Asp248 had rotated, as expected, from its position seen in the
unliganded enzyme (Figure 4A) to form an acylal ester with
a 1.4 A˚ bond linking the anomeric carbon of 5-F-GlcNAc to
Asp248 (Figure 4A).
The pyranose ring of the 5-F-GlcNAcmoiety itself adopts a 4C1
chair conformation. Given the conservation of both the 1
subsite and the position of the conserved Asp nucleophile, it is
likely that all GH3 NagZ enzymes form a transient glycosyl-
enzyme intermediate adopting such a conformation. This finding
is consistent with the 4C1 conformation observed for the covalent
intermediate formed by the GH3 b-glucanase HvExoI (Hrmova
et al., 2001) and other configuration-retaining b-glycosidases
(Davies et al., 1998; Notenboom et al., 1998; Vocadlo et al.,
2001). The substrate distortion in the experimentally determined
and modeled Michaelis complexes of BsNagZ (Figure 3D) and
StNagZ (Figure 3C), respectively, combined with the covalent2, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1475
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Figure 3. Catalytic Loop Mobility and Active Site Architecture of StNagZ and BsNagZ
(A) Superposition of the active site region and catalytic loop (blue) of StNagZ (gray) and BsNagZ (salmon) bound to disaccharide substrate. Only the GlcNAc-
MurNAc substrate bound to BsNagZ is shown as sticks for clarity (yellow and cyan carbons are of the substrate bound to the triclinic and monoclinic forms of
BsNagZ, respectively; nitrogens are blue, oxygens are red). Dashed lines delimit the distance of the Nε2 atom of the catalytic histidine of each enzyme from the
glycosidic oxygen of GlcNAc-MurNAc.
(B) Active site of StNagZ bound to GlcNAc-anhMurNAc (GlcNAc bound as a 4C1 chair).
(C) Model predicting the StNagZ Michaelis complex bound to distorted GlcNAc-anhMurNAc (scissile bond is pseudoaxial). The model was constructed as
follows: the anhMurNAc leaving group of GlcNAc-anhMurNAc in the crystallographic StNagZ substrate complex was distorted into a pseudoaxial orientation
(which was later verified by superposing this model onto the distorted conformation of GlcNAc-MurNAc in the triclinic BsNagZ complex). A slight rotation of
anhMurNAc about the glycosidic bond allowed an effective hydrogen-bonding interaction with Arg70. The conformation of the catalytic loop and position of
His176 was modeled based on its conformation in the crystal structure of BsNagZ bound to PUGNAc (Litzinger et al., 2010b). This conformation was also later
verified by comparing it to the triclinic BsNagZ substrate complex.
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Figure 4. Covalent Glycosyl-Enzyme Intermediate and Product
Complex of StNagZ
(A) Superposition of unliganded StNagZ (light gray) and StNagZ bound to 5-F-
GlcNAc (dark gray).
(B) StNagZ bound to GlcNAc. Active site residues and ligands are drawn as
sticks with oxygen and nitrogen atoms shown in red and blue, respectively.
Carbon atoms of the enzyme are shown in light or dark gray, whereas the
carbon atoms of bound ligands are yellow. Hydrogen bonds are shown as
yellow dashed lines. Electron densities (cyan) are maximum-likelihood
weighted 2Fobs  Fcalc syntheses contoured at 1s.
See Tables S1 and S2 as well.
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GH3 NagZ enzymes impose a 1S34
4H34
4C1 conformational
itinerary on the sugar bound in the 1 subsite.
The GlcNAc Product Binds the –1 Subsite in a Relaxed
4C1 Chair Conformation
A structure of the StNagZ product complex was determined by
soaking crystals of the wild-type enzyme with GlcNAc (Table(D) Active site of triclinic BsNagZ bound to distorted GlcNAc-MurNAc (scissile bo
oxygen of the substrate. A small amount of GlcNAc (green carbons) also appears
the disaccharide and GlcNAc sugar were refined to 0.66/0.60 and 0.34/0.40, res
(E) Active site of monoclinic BsNagZ bound to GlcNAc-MurNAc (GlcNAc bound as
greater flexibility of this sugar. For (B)–(E), electron density maps (cyan) are maxi
disaccharide substrates. Hydrogen bonds are shown as yellow dashed lines.
See also Figures S1–S3 and Tables S1 and S2.
Chemistry & Biology 19, 1471–148S2), and the resulting structure was refined to 1.35 A˚ resolution.
Electron density revealed a mixture of b- and a-anomers of
GlcNAc bound to the 1 subsite of the enzyme in a 4C1 chair
conformation, presumably due to mutarotation (Figure 4B). The
observation that the product binds in a relaxed conformation
appears inconsistent with the conformational distortion of the
substrate required for catalysis by NagZ and other families of
glycoside hydrolases. Indeed, because the breakdown of the
glycosyl-enzyme intermediate is the near-microscopic reverse
of its formation, one would expect that the product should bind
in an identical 1S3 conformation such that the entire itinerary
would follow a 1S3 (substrate) /
4H3 (first transition state) /
4C1 (intermediate) /
4H3 (second transition state) /
1S3
(product) pathway. Insight into why a relaxed 4C1 chair confor-
mation is observed in StNagZ can be gleaned, however, from
previous data and a consideration of the structural features
that enable substrate distortion.
We noted in the triclinic BsNagZ-GlcNAc-MurNAc complex
that whereas the strongest electron density could be ascribed
to intact disaccharide, a small amount of free GlcNAc was also
bound in the 1 subsite (Figure 3D). Density in the 1 subsite
dictated that the free GlcNAc product be modeled in a 4C1 chair
conformation, whereas when this sugar was coupled to MurNAc
as part of the disaccharide, it adopted a conformation close to
a 1S3 skew boat to accommodate the pseudoaxial orientation
of the MurNAc leaving group (Figure 3D). The presence of these
two conformations of GlcNAc within the complex indicates that
distortion of the sugar toward a 1S3 skew boat requires an intact
glycosidic bond and leaving group, which NagZ binds in a pseu-
doaxial position through interactions in the +1 subsite, as well as
by repositioning of the catalytic loop to engage the glycosidic
oxygen (Figure 3D). In this regard, it is notable that a similar
requirement for the presence of an aglycone leaving group was
used to explain the absence of distortion of a glucose residue
in the 1 subsite of Cel5A from Bacillus agaradhaerens (Davies
et al., 1998). Our observations are therefore consistent with a
general requirement for substrate distortion in retaining b-glyco-
sidases being an intact scissile bond spanning the 1 and +1
subsites.
Conclusions
The structural studies presented here provide insight into an
unusually flexible group of glycoside hydrolases. The flexibility
of NagZ enzymes may stem from variability in the natural
substrates they process. Indeed, these enzymes can remove
GlcNAc from simple disaccharides or muropeptides with stem
peptides of various lengths. Collectively, the NagZ structures
described here reveal that the catalytic loop and enzymic nucle-
ophile undergo significant conformational changes during catal-
ysis. These structural changes could be exploited to develop
improved NagZ inhibitors as a possible therapeutic approachnd is pseudoaxial) with the His234 of the catalytic loop engaging the glycosidic
to be present, likely due to slow turnover of the disaccharide. Occupancies for
pectively, in both monomers of the asymmetric unit.
a 4C1 chair). MurNAc lacks interaction with the enzyme, thereby likely allowing
mum-likelihood weighted 2Fobs  Fcalc syntheses contoured at 1s around the
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Snapshots along the Reaction Coordinate of NagZto suppress AmpC induction and reverse b-lactam resistance in
Gram-negative bacteria (Mark et al., 2011; Yamaguchi et al.,
2012). It is also interesting to note that the amidase AmpD of
the Gram-negative PG recycling pathway also undergoes large
structural rearrangements during catalysis (Carrasco-Lo´pez
et al., 2011).
The plasticity of NagZ enzymes appears to facilitate confor-
mational changes in the disaccharide substrates, ultimately
resulting in distortion of the bound GlcNAc sugar toward a 1S3
conformation, which has been noted to occupy a local energy
minimum (Biarne´s et al., 2007). A structure of StNagZ trapped
at the intermediate step of the reaction, however, revealed that
the GlcNAc residue of the intermediate adopts a 4C1 con-
formation. Furthermore, hydrolysis of this intermediate leads
to formation of a GlcNAc product that binds StNagZ in a re-
laxed conformation (4C1). Thus, after substrate distortion has
occurred, the reaction coordinate is primarily defined by move-
ment of the anomeric center (C1) from a pseudoaxial position
above the plane of the GlcNAc pyranose ring to a position where
it forms a covalent bond with the catalytic nucleophile.
Such an electrophilic migration mechanism involving a highly
dissociative oxocarbenium ion-like transition state is well sup-
ported among glycoside hydrolases through a-D-kinetic isotope
effects that have almost universally been both normal and large
in magnitude. Indeed, such isotope effects have shown V. furnisii
NagZ uses a catalytic mechanism involving a highly dissociative
transition state (Vocadlo and Withers, 2005). Such a transition
state, in which the C5-O5-C1-C2 atoms adopt a planar configu-
ration, has been proposed to be general for glycoside hydrolases
(Davies et al., 1998; Vocadlo et al., 2001) and is supported by
studies of transition-state analogs having similar planar configu-
ration bound to glycoside hydrolases (Tailford et al., 2008). The
conformational itinerary followed by NagZ enzymes is therefore
most likely the 1S34
4H34
4C1 pathway observed for several
other families of retaining b-glycoside hydrolases (Vocadlo and
Davies, 2008). Distortion of the b-configured substrates from
a 4C1 conformation, which is generally preferred in solution,
toward a 1S3 conformation has been suggested to bring the
pyranose ring closer to the oxocarbenium ion-like transition state
(where C5-O5-C1-C2 are coplanar) (Biarne´s et al., 2006) and
permits in-line nucleophilic attack on the s* antibonding orbital
of the anomeric carbon (Davies et al., 1998; Sulzenbacher
et al., 1996). Indeed, the potent inhibition of NagZ observed for
PUGNAc (Stubbs et al., 2007) likely arises from its geometric
resemblance to this flattened oxocarbenium ion-like transition
state. Although detailed kinetic studies will be needed to unam-
biguously assign the histidine within the catalytic loop as the
general acid/base of NagZ enzymes, the observed substrate
distortion is consistent with it acting in this capacity because
we observe it forming a hydrogen bond with the glycosidic
oxygen. The distortion also agrees with stereoelectronic theory,
because the pseudoaxial orientation of the glycosidic bond
maximizes the ability of the endocyclic oxygen O5 to donate
its nonbonding electrons to the anomeric carbon and thereby
delocalize positive charge that develops at the anomeric carbon
during the transition state (Kirby, 1984).
Although the substrate distortion observed in the crystallo-
graphic and modeled Michaelis complexes of BsNagZ and
StNagZ, respectively, are in agreement with crystal structures1478 Chemistry & Biology 19, 1471–1482, November 21, 2012 ª2012of Michaelis complexes of other retaining b-glycosidases, they
contrast with Michaelis complexes of the GH3 b-glucanase
HvExo1, which has been bound to two different nonhydrolyz-
able S-glycoside substrate analogs (Hrmova et al., 2001,
2002). Although the disaccharide analogs span the 1 to +1
subsites, no distortion was observed for the sugar bound to
the 1 subsite. In particular, two tryptophan residues (Trp434
and Trp286) pack on either side of the sugar in the +1 subsite
such that it is held fixed in place. This packing blocks the possi-
bility of distorting the sugar in the 1 subsite and prevents
placing the sugar leaving group in a position that might enable
the nonhydrolyzable glycosidic bond in a pseudoaxial orienta-
tion, which thereby keeps the sugar in the 1 subsite in a 4C1
conformation. These tryptophan residues are absent in the +1
subsite of GH3 NagZ enzymes, and thus free rotation of the
glycosidic bond and leaving group into an axial position is
possible. A Trp-Trp clamp, and related Phe-Phe clamp, are
also prominent structural features of the +1 subsites of addi-
tional multidomain GH3 b-glucanases (Nakatani et al., 2012;
Yoshida et al., 2010). Given the catalytic advantages that sub-
strate distortion offers retaining b-glycoside hydrolases, a
mechanism not requiring this step in a subset of GH3 enzymes
seems uncertain. Given that we observe both pre-Michaelis and
Michaelis complexes in GH3 NagZ enzymes that are coupled
with remarkable active site plasticity, further study may be
warranted to probe the possibility that substrate distortion
occurring through conformational changes is a general feature
of all GH3 enzymes.
SIGNIFICANCE
NagZ participates in peptidoglycan (PG) recycling by
removing b-N-acetylglucosamine (GlcNAc) from PG frag-
ments that are excised from the bacterial cell wall during
growth. Notably, the 1,6-anhydroMurNAc-peptide products
formed by NagZ activate AmpC b-lactamase expression
in numerous pathogenic Gram-negative bacteria, making
NagZ a potential drug target to suppress AmpC-mediated
b-lactam antibiotic resistance. Snapshots along the reac-
tion coordinate of NagZ from Salmonella typhimurium and
Bacillus subtilis obtained through X-ray structural analysis
using synthetically prepared natural substrates and amech-
anism-based inhibitor reveal an unusual degree of structural
plasticity within the active site of a glycoside hydrolase.
NagZ enables distortion of the bound terminal GlcNAc sugar
toward a 1S3 conformation, using a highly mobile loop that
contains a histidine proposed as the general acid/base.
The distortion repositions the substrate leaving group into
a pseudoaxial orientation and allows the catalytic histidine
access to the glycosidic oxygen, thereby forming a produc-
tive Michaelis complex. Collectively, these findings demon-
strate that flexibility in the active site structure of GH3 NagZ
enzymes drives the substrate along a 1S34
4H34
4C1 confor-
mational itinerary that is in keeping with structurally rigid
b-glycosidases. The observed correlation between enzyme
flexibility and catalysis may now be exploited to generate
improved NagZ inhibitors as a possible therapeutic ap-
proach to suppressing b-lactam antibiotic resistance in
Gram-negative bacteria.Elsevier Ltd All rights reserved
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Expression Plasmid Construction
Open reading frames of nagZ genes from S. typhimurium (National Center for
Biotechnology Information [NCBI] Gene ID code AAL20138.1) and B. subtilis
(NCBI Gene ID code NP_388047.1) were PCR amplified from laboratory stocks
of genomic DNA using oligonucleotide primers (Alpha DNA) listed in Table S3.
The PCR amplicons were then restricted with NdeI and BamHI. The restricted
S. typhimurium nagZ amplicon was ligated into a linearized version of a pET28
plasmid (Novagen) containing a reduced multicloning site (Nde1/Spe1/
BamH1) and C-terminal His6 tag, whereas the B. subtilis nagZ amplicon was
ligated into a version of a pET28 plasmid (Novagen) containing a reduced
multicloning site (Nde1/Spe1/BamH1) with an N-terminal His6 and thrombin
cleavage site that replaces the putative peptidase signal sequence at the N
terminus of native BsNagZ. Ligation products generated for each construct
were used to transform E. coli strain BL21(DE3) GOLD cells (Stratagene).
Transformants were selected in Luria broth (LB) agar supplemented
with 50 mg/ml kanamycin. An expression plasmid containing either the
S. typhimurium nagZ gene (pSTnagz) or B. subtilis nagZ gene (pBSnagz)
was isolated from single kanamycin-resistant transformants and confirmed
by DNA sequencing.
Site-directed mutagenesis was performed using the QuikChange Lightning
Site-Directed Mutagenesis Kit (Stratagene). Oligonucleotide primers used to
generate the enzyme variants are listed in Table S3. The complete open
reading frame of each nagZ variant was verified by DNA sequencing.
NagZ Expression and Purification
E. coli BL21(DE3) GOLD cells harboring either pSTnagz or pBSnagz
were grown to an optical density of 0.5–0.6 (OD600) at 37
C, with shaking,
in 500 ml volumes of LB media supplemented with 35 mg/ml kanamycin.
Expression of the NagZ proteins was induced with 1 mM isopropyl-b-D-1-
thiogalactopyranoside for 4 hr at 28C (StNagZ) or 3 hr at 37C (BsNagZ),
with shaking. Cells were pelleted by centrifugation and stored at 80C.
Pellets were thawed in 20 ml of ice-cold lysis buffer (1 M NaCl, 20 mM Tris
[pH 8], and 1 mM phenylmethanesulfonyl fluoride [PMSF] for StNagZ or
0.5 M NaCl, 20 mM Tris [pH 7.5], 2 mM imidazole, and 0.1 mM PMSF for
BsNagZ) and lysed using a French pressure cell press (Ameco).
Lysates containing wild-type StNagZ or site-directed variants thereof were
clarified by centrifugation and loaded onto an Ni-NTA agarose (QIAGEN)
column that had been pre-equilibrated with binding buffer (1 M NaCl and
50 mM Tris [pH 8]). The column was washed with ten column volumes (CVs)
of binding buffer, followed by two additional ten CVwashes with binding buffer
supplemented with 25 and 50 mM imidazole (Sigma), respectively. Recombi-
nant protein was eluted from the column using binding buffer supplemented
with 250 mM imidazole. Chromatographic steps were performed using an
AKTA fast protein liquid chromatography system (GE Healthcare). The eluate
was dialyzed overnight against 150 mMNaCl and 20 mM BisTris (pH 6.5) prior
to concentration using an Amicon concentrator (10,000 molecular weight
cutoff [MWCO]).
Lysates containing wild-type BsNagZ or site-directed variants thereof were
clarified by centrifugation and mixed with 2 ml of TALON metal-affinity resin
(Clontech) with gentle shaking for 30 min at room temperature. The resin
was pelleted and then resuspended in lysis buffer before being poured into
a 20 ml gravity column. The resin was washed with 20 ml of binding buffer
(500 mM NaCl, 20 mM Tris [pH 7.5]) supplemented with 5 mM imidazole,
followed by 20 ml of binding buffer supplemented with 10 mM imidazole.
Recombinant protein was eluted from the column with 10 ml of binding buffer
supplemented with 500 mM imidazole. The eluate was dialyzed overnight
against 20 mM Tris (pH 7.5) and 500 mMNaCl and further purified by gel filtra-
tion using a Superdex 200 column pre-equilibrated with the dialysis buffer.
Following gel filtration, the protein was concentrated using an Amicon concen-
trator (10,000 MWCO). All purification steps were conducted at 4C.
Crystallization and X-Ray Data Collection
StNagZ crystals (native and variants) were grown at room temperature using
the hanging-drop vapor-diffusion method by mixing equal volumes of
reservoir buffer (25% PEG1000 and 0.1 M MES [pH 6.5]) and protein solution
(6–9 mg/ml) in crystallization buffer (150 mMNaCl and 20mMBisTris [pH 6.5]).Chemistry & Biology 19, 1471–148StNagZ crystals were then soakedwith ligand to obtain the complexes listed in
Table S2. The 25%PEG1000 present in the crystallization buffer was sufficient
for cryoprotection, and crystals were harvested by flash-cooling in liquid
nitrogen. The BsNagZ D318N variant was crystallized at room temperature
using the hanging-drop vapor-diffusion method by mixing equal volumes of
reservoir buffer (22% PEG3350 for the triclinic form; 22% PEG3350 and
0.2 M potassium formate for the monoclinic form) and protein solution
(20 mg/ml) in crystallization buffer (20 mM Tris [pH 7.5] and 500 mM NaCl).
BsNagZ crystals were then soaked with ligand to obtain the complexes listed
in Table S2. The ligand-bound crystals were then cryoprotected by briefly
soaking in reservoir buffer supplemented with 9% sucrose (w/v), 2% glucose
(w/v), 8% glycerol (v/v), and 8% ethylene glycol (v/v) prior to flash-cooling in
liquid nitrogen.
X-ray diffraction data were collected at beamline 08ID-1 at the Canadian
Light Source (Saskatoon, Canada), with the exception of data from the StNagZ
D248N substrate complex, which were instead collected using a Rigaku
R-AXIS VI++ detector and MicroMax HF generator. Diffraction data were
integrated using XDS (Kabsch, 2010), except for data collected from the native
StNagZ structure, the StNagZ D248N substrate complex, and the triclinic
BsNagZ D318N substrate complex, which were instead integrated using
MOSFLM (Leslie, 1992). All integrated data were scaled and merged using
SCALA (Evans, 2006) (Table S1).
Structure Determination and Refinement
Structures of unliganded wild-type StNagZ and triclinic BsNagZ (D318N) were
determined by molecular replacement using the program Phaser (McCoy
et al., 2005) and the crystal structures of V. cholerae NagZ (PDB ID code
2OXN) (Stubbs et al., 2007) and wild-type BsNagZ (PDB ID code 3BMX) as
search models, respectively. Prior to refinement, a random subset of hkl
indices for each structure was flagged for cross-validation against the free R
factor (Bru¨nger, 1992) and used for all subsequent structure determinations
of each enzyme. The structures of both proteins were subsequently rebuilt
using the PHENIX autobuild routine, prior to iterative rounds of model building
and refinement using Coot and phenix.refine (Adams et al., 2010; Emsley and
Cowtan, 2004). The refined structures of unliganded StNagZ and triclinic
BsNagZ (D318N) served as starting models for rigid-body refinement and
subsequent rounds of restrained refinement and model building of ligand-
bound forms of each enzyme. The refined triclinic structure of BsNagZ
(D318N) also served as the MR search model to determine the monoclinic
crystal structure of BsNagZ (D318N) using the program Phaser (McCoy
et al., 2005). The structure of the monoclinic form of BsNagZ (D318N) was
subsequently rebuilt using the PHENIX autobuild routine prior to further rounds
of refinement as described above.
Ligand restraint files were generated using phenix.elbow or JLigand
(Lebedev et al., 2012), and ligand models were initially fit into electron density
using PHENIX Ligandfit (Adams et al., 2010). Solvent molecules were added
using PHENIX, and final refinement of all the models, ligands, and solvent
was performed using Coot and PHENIX. Stereochemical quality of all final
models was assessed using MolProbity (Chen et al., 2010). The final refine-
ment statistics are presented in Table S1.
Synthesis of Substrates
GlcNAc-AnhMurNAc Substrates
Acid: 2-Acetamido-4-O-(2-Acetamido-2-Deoxy-b-D-Glucopyranosyl)-1,6-
Anhydro-2-Deoxy-3-O-[(1R)-1-Carboxyethyl]-b-D-Glucopyranose (1) (Fig-
ure S1). The title compound was prepared according to literature methods
(Paulsen et al., 1986).
Methyl Ester: 2-Acetamido-4-O-(2-Acetamido-2-Deoxy-b-D-Glucopyrano-
syl)-1,6-Anhydro-2-Deoxy-3-O-[(1R)-1-(Methoxycarbonyl)ethyl]-b-D-Glucopyr-
anose (2) (Figure S1). Sodiummethoxide (10 mg) was added to the triacetate 4
(Paulsen et al., 1986) (150 mg, 0.24 mmol) in MeOH (5 ml) and the solution was
stirred (room temperature, 30 min). The mixture was quenched with resin
(Amberlite IR-120, H+), filtered, and concentrated to yield the methyl ester 2
as a colorless foam (115 mg, 96%). 1H NMR (600 MHz, CD3OD) 5.18 (s, 1H),
4.55 (d, J 5.4 Hz, 1H), 4.49 (d, J 8.4 Hz, 1H), 4.30 (q, J 6.6 Hz, 1H), 4.17 (dd,
J 0.6, 7.2 Hz, 1H), 4.10 (s, 1H), 3.89 (dd, J 1.8, 12.0 Hz, 1H), 3.83 (s, 1H),
3.77–3.73 (m, 1H), 3.72 (s, 3H), 3.68–3.62 (m, 2H), 3.45–3.41 (m, 2H), 3.32–
3.28 (m, 2H), 2.06 (s, 3H), 2.01 (s, 3H), 1.36 (d, J 6.6 Hz, 3H); 13C NMR2, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1479
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74.5, 74.2, 72.1, 65.8, 62.7, 57.0, 52.5, 51.2, 23.4, 22.7, 18.8; HR-MS m/z
(FAB) 493.2045 (M+H)+ requires 493.2033. Analytical calculated for
C20H32N2O12: C, 48.78%; H, 6.55%. Found: C, 48.95%; H, 6.51%.
Amide: 2-Acetamido-4-O-(2-Acetamido-2-Deoxy-b-D-Glucopyranosyl)-1,6-
Anhydro-2-Deoxy-3-O-[(1R)-1-(Amido)ethyl]-b-D-Glucopyranose (3) (Figure
S1). Saturated ammonia in methanol (2 ml) was added to the methyl ester 2
(50 mg, 0.10 mmol) in MeOH (5 ml) and the solution was stirred (room temper-
ature, 8 hr). The mixture was concentrated to yield the amide 3 as a colorless
foam (46 mg, 96%). 1H NMR (600 MHz, CD3OD/D2O) 5.45 (s, 1H), 4.70
(d, J 5.6 Hz, 1H), 4.67 (d, J 8.4 Hz, 1H), 4.24 (d, J 7.9 Hz, 1H), 4.18
(q, J 6.7 Hz, 1H), 4.02 (s, 1H), 3.98 (s, 1H), 3.90 (dd, J 2.0, 12.4 Hz, 1H),
3.82–3.75 (m, 3H), 3.61–3.56 (m, 2H), 3.49–3.44 (m, 2H), 2.09 (s, 3H), 2.07
(s, 3H), 1.39 (d, J 6.7 Hz, 3H); 13C NMR (150 MHz, CD3OD/D2O) 179.6,
176.2, 174.6, 101.8, 100.8, 77.9, 77.0, 76.5, 75.2, 74.6, 74.3, 70.7, 65.7,
61.5, 56.5, 50.4, 23.3, 22.8, 19.1; HR-MS m/z (FAB) 478.2053 (M+H)+ requires
478.2037. Analytical calculated for C19H31N3O11: C, 47.79%; H, 6.54%.
Found: C, 47.77%; H, 6.60%.
2-Acetamido-2-Deoxy-5-Fluoro-b-D-Glucopyranosyl Fluoride. Prepared
according to Stubbs et al. (2008).
Enzyme Assays and Kinetics
Substrates and products of the enzymatic reactions were separated by
high-performance anion-exchange chromatography using a Dionex ICS
3000 system equipped with an ASI 100 automated sample injector (Dionex)
and an ED50 electrochemical detector (Dionex) with a gold working electrode
and an Ag/AgCl reference electrode. All enzyme reactions were carried out in
duplicate at 37C. A 50 ml assay volumewas used containing 12.5 ml of 43PBS
(200 mM NaH2PO4 and 400 mM NaCl) to generate a buffered solution having
a pH value of 7.4. Assays were initiated by the addition of enzyme (2.5 ml,
2.08 mg/ml of enzyme in the assay), allowed to proceed for 10 min, and then
stopped by the addition of 200 ml of anhydrous ethanol. The mixture was
immediately vortexed for 20 s and cooled to 20C for 30 min. Precipitated
protein was removed by centrifugation at 14,000 rpm and 4C for 5 min in a
microfuge (Eppendorf 1.5 ml). The supernatant containing mono- and disac-
charides was carefully removed from each tube, transferred to a new tube,
and evaporated to dryness using a vacuum centrifuge. All samples were re-
constituted in 200 ml water. A 20 ml injection volume of each sample was sepa-
rated using a PA-20 column set (analytical column equipped with a guard
column) and a 100 mM NaOH isocratic gradient for 20 min. Standard calibra-
tion curves were generated for both GlcNAc and GlcNAc-anhMurNAc and
were used to quantify the amount of substrate and product remaining after
each assay. The standard calibration curves for both the product and
substrate were analyzed at pH 7.4 and ranged from 1 to 500 mM. Substrate
specificity assays of wild-type StNagZ (2.08 mg/ml) were carried out using
GlcNAc-anhMurNAc, GlcNAc-anhMurNAc amide, and GlcNAc-anhMurNAc
methyl ester. Each substrate was individually incubated at concentrations of
100 and 500 mM with wild-type NagZ at 37C for 10 min using the aforemen-
tioned stopped assay procedure.
Steady-state kinetic studies were performed using a continuous assay,
which monitored the product, 4-methylumbelliferone, of the enzyme-
catalyzed digestion of the substrate, 4-methylumbelliferone 2-acetamido-2-
deoxy-b-D-glucopyranoside (4-Mu-b-GlcNAc). A 96-well plate (Sarstedt) and
plate reader (Molecular Devices) were used, with the excitation wavelength
set at 355 nm and the emission wavelength at 485 nm, to monitor the release
of 4-methylumbelliferone at 37C over a period of 30 min. All assays were
carried out in triplicate. A 200 ml assay volume composed of PBS (200 mM
NaH2PO4 and 400 mM NaCl [pH 7.4]) was used for all assays. The substrate
concentration in assays ranged from 0.005 to 3.3 mM. Assays were initiated
by the addition of enzyme (20 ml).
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